Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel

被引:52
作者
Richter, James A. [1 ]
Patrie, James T. [2 ]
Richter, Robert P. [1 ]
Henry, Zachary H. [3 ]
Pop, George H. [3 ]
Regan, Kara A. [3 ]
Peura, David A. [1 ]
Sawyer, Robert G. [4 ]
Northup, Patrick G. [1 ]
Wang, Andrew Y. [1 ]
机构
[1] Univ Virginia, Div Gastroenterol & Hepatol, Charlottesville, VA USA
[2] Univ Virginia, Div Biostat & Epidemiol, Charlottesville, VA USA
[3] Univ Virginia, Dept Med, Charlottesville, VA USA
[4] Univ Virginia, Dept Surg, Charlottesville, VA USA
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL HEMORRHAGE; ANTIPLATELET AGENTS; COLONOSCOPIC POLYPECTOMY; MYOCARDIAL-INFARCTION; PRIMARY-CARE; RISK-FACTORS; DOUBLE-BLIND; ANTIDEPRESSANTS; THERAPY;
D O I
10.1016/j.gie.2011.03.1258
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Percutaneous endoscopic gastrostomy (PEG) is an invasive procedure that can result in bleeding. Guidelines recommend discontinuing clopidogrel for 7 to 10 days, but not withholding aspirin, before PEG. Serotonin reuptake inhibitors (SRIs) have been associated with an increased risk of GI bleeding. Objective: To determine whether there is an association between periprocedural aspirin, clopidogrel, or SRI use and bleeding in patients who underwent PEG tube placement. Design: Retrospective cohort study. Setting: Large quaternary-care academic medical center. Patients: A total of 990 patients (525 men) with a median age of 69.8 years who underwent PEG from January 1999 to April 2009. Interventions: PEG tube placement. Main Outcome Measurements: GI bleeding. Results: Sixteen patients (1.6%) had evidence of bleeding during the first 48 hours after PEG, and 12 patients (1.2%) had evidence of bleeding between 48 hours and 14 days after PEG. Thirty-six patients (3.6%) received high-dose aspirin (>325 mg), 27 patients (2.7%) received clopidogrel (75 mg), and 99 patients (10%) received an SRI before PEG. Twenty-four patients (2.4%) received high-dose aspirin, 25 patients (2.5%) received clopidogrel, and 130 patients (13.1%) received an SRI after PEG. Multivariate analysis demonstrated no association between periprocedural use of aspirin (at any close) or clopiclogrel and post-PEG bleeding. However. SRIs administered 24 hours or less before PEG were associated with a significantly higher odds of post-PEG bleeding (adjusted odds ratio 4.1; 95% CI, 1.1-13.4; P = .04). Limitations: Retrospective, single-center study with limited statistical power despite a relatively large cohort of patients. Conclusions: Use of aspirin or clopidogrel before or after PEG was not associated with procedure-related bleeding. SRI use in the 24 hours before PEG was associated with an increased risk of bleeding. (Gastrointest Enclose 2011;74:22-34.)
引用
收藏
页码:22 / 34
页数:13
相关论文
共 77 条
[1]  
ABADSANTOS F, 1995, CLIN LAB HAEMATOL, V17, P195
[2]   Management of antithrombotic agents for endoscopic procedures [J].
Anderson, Michelle A. ;
Ben-Menachem, Tamir ;
Gan, S. Ian ;
Appalaneni, Vasundhara ;
Banerjee, Subhas ;
Cash, Brooks D. ;
Fisher, Laurel ;
Harrison, M. Edwyn ;
Fanelli, Robert D. ;
Fukami, Norio ;
Ikenberry, Steven O. ;
Jain, Rajeev ;
Khan, Khalid ;
Krinsky, Mary Lee ;
Lichtenstein, David R. ;
Maple, John T. ;
Shen, Bo ;
Strohmeyer, Laura ;
Baron, Todd ;
Dominitz, Jason A. .
GASTROINTESTINAL ENDOSCOPY, 2009, 70 (06) :1060-1070
[3]  
[Anonymous], 1991, Lancet, V338, P1345
[4]  
[Anonymous], LEXAPRO REVISED LABE
[5]  
[Anonymous], PROZAC REVISED LABEL
[6]  
[Anonymous], 1991, N ENGL J MED, V324, P1670
[7]  
[Anonymous], ZOLOFT REVISED LABEL
[8]  
[Anonymous], PAXIL REVISED LABEL
[9]  
[Anonymous], EFFEXOR REVISED LABE
[10]  
[Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI [DOI 10.1056/NEJM198907203210301, 10.1056/NEJM198907203210301.]